$100 a share?!!! This company can't even get above a $1. I've seen recent companies granted phase 1 approval shoot up over $5. Makes you wonder that those in the know, professional market analysts, haven't jumped in on a possible 100x. Maybe its because they know something. And why spend 500K on a large table at ASCO? Only significant news posted on company website since last years ASCO is approval for sawston. Unless they are withholding info......
I know, I know...quiet period, virus, war in ukraine, supply issues, funding, magazines fault, trapping shorts, lawsuits etc etc...
so much for end of 1st quarter predictions. next..